HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Muye Xia Selected Research
Muye Xia Research Topics
Disease
11
Chronic Hepatitis B
02/2023 - 02/2017
4
Infections
11/2023 - 06/2017
2
Acquired Immunodeficiency Syndrome (AIDS)
04/2024 - 11/2023
2
Hepatitis B
01/2021 - 01/2018
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2024
1
Shock
11/2023
1
Liver Cirrhosis (Hepatic Cirrhosis)
02/2023
1
Fever (Fevers)
01/2023
1
Human Influenza (Influenza)
01/2023
1
Virus Diseases (Viral Diseases)
01/2019
1
Type 2 Diabetes Mellitus (MODY)
02/2017
Drug/Important Bio-Agent (IBA)
5
Hepatitis B e Antigens
IBA
02/2023 - 01/2018
4
Antiviral Agents (Antivirals)
IBA
02/2023 - 01/2021
2
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2022 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 02/2017
2
RNA (Ribonucleic Acid)
IBA
01/2021 - 01/2020
1
Ligands
IBA
04/2024
1
Proteins (Proteins, Gene)
FDA Link
11/2023
1
obatoclax
IBA
11/2023
1
Alanine Transaminase (SGPT)
IBA
02/2023
1
DNA (Deoxyribonucleic Acid)
IBA
02/2023
1
Nucleotides
IBA
02/2023
1
Oseltamivir (Tamiflu)
FDA Link
01/2023
1
baloxavir
IBA
01/2023
1
nas
IBA
01/2021
1
Antigens
IBA
01/2021
1
Enzymes
IBA
01/2021
1
MicroRNAs (MicroRNA)
IBA
01/2019
1
Telbivudine
FDA Link
06/2017
1
entecavir
FDA Link
06/2017
1
Interferons
IBA
06/2017
1
Lipids
IBA
02/2017
1
Uric Acid (Urate)
IBA
02/2017
Therapy/Procedure
7
Therapeutics
11/2023 - 06/2017
1
Aftercare (After-Treatment)
01/2022
1
Retreatment
01/2021